A mathematical model for predicting the spatiotemporal response of breast cancer cells treated with doxorubicin
Related Experiment Video
Updated: May 5, 2026
Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
Published on: November 20, 2011
Hugo J M Miniere1, Ernesto A B F Lima2, Guillermo Lorenzo2,3
1Department of Biomedical Engineering, The University of Texas at Austin, Austin, USA.
Abstract:
Tumor heterogeneity contributes significantly to chemoresistance, a leading cause of treatment failure. To better personalize therapies, it is essential to develop tools capable of identifying and predicting intra- and inter-tumor heterogeneities. Biology-inspired mathematical models are capable of attacking this problem, but tumor heterogeneity is often overlooked in in-vivo modeling studies, while phenotypic considerations capturing spatial dynamics are not typically included in in-vitro modeling studies. We present a data assimilation-prediction pipeline with a two-phenotype model that includes a spatiotemporal component to characterize and predict the evolution of in-vitro breast cancer cells and their heterogeneous response to chemotherapy. Our model assumes that the cells can be divided into two subpopulations: surviving cells unaffected by the treatment, and irreversibly damaged cells undergoing treatment-induced death. MCF7 breast cancer cells were previously cultivated in wells for up to 1000 hours, treated with various concentrations of doxorubicin and imaged with time-resolved microscopy to record spatiotemporally-resolved cell count data. Images were used to generate cell density maps. Treatment response predictions were initialized by a training set and updated by weekly measurements. Our mathematical model successfully calibrated the spatiotemporal cell growth dynamics, achieving median [range] concordance correlation coefficients of > .99 [.88, >.99] and .73 [.58, .85] across the whole well and individual pixels, respectively. Our proposed data assimilation-prediction approach achieved values of .97 [.44, >.99] and .69 [.35, .79] for the whole well and individual pixels, respectively. Thus, our model can capture and predict the spatiotemporal dynamics of MCF7 cells treated with doxorubicin in an in-vitro setting.
Insights
This study introduces a novel mathematical model to predict how breast cancer cells respond to chemotherapy. The model accurately captures and forecasts the spatiotemporal dynamics of tumor cell populations, aiding in personalized treatment strategies.
Area of Science:
- Computational Biology
- Cancer Research
- Mathematical Modeling
Background:
- Tumor heterogeneity is a major driver of chemoresistance and treatment failure.
- Existing in vivo models often neglect tumor heterogeneity, while in vitro models lack spatial dynamics.
- Personalized therapies require tools to predict intra- and inter-tumor heterogeneities.
Purpose of the Study:
- To develop and validate a data assimilation-prediction pipeline with a two-phenotype, spatiotemporal mathematical model.
- To characterize and predict the evolution of in vitro breast cancer cell heterogeneity under chemotherapy.
- To assess the model's accuracy in capturing MCF7 breast cancer cell dynamics treated with doxorubicin.
Main Methods:
- A two-phenotype mathematical model incorporating spatiotemporal components was developed.
- MCF7 breast cancer cells were cultured, treated with doxorubicin, and imaged using time-resolved microscopy.
- Cell density maps were generated, and a data assimilation-prediction pipeline updated treatment response predictions using weekly measurements.
Main Results:
- The mathematical model achieved high concordance correlation coefficients (>0.99) for spatiotemporal cell growth dynamics across the whole well.
- Model calibration demonstrated strong predictive power, with coefficients of 0.73 for individual pixels.
- The data assimilation-prediction approach showed significant accuracy (0.97 for whole well, 0.69 for pixels) in predicting treatment response.
Conclusions:
- The proposed model successfully captures and predicts the spatiotemporal dynamics of MCF7 breast cancer cells treated with doxorubicin in vitro.
- This approach offers a promising tool for understanding and predicting heterogeneous responses to chemotherapy.
- The findings support the development of more personalized cancer treatment strategies by accounting for cell dynamics.
